We are live on ! Find out more
FOMX

Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX

Delisted

FOMX was delisted on the 6th of March, 2020.

Back to rankings

67 hedge funds and large institutions have $113M invested in Foamix Pharmaceuticals Ltd. Ordinary Shares in 2017 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 19 increasing their positions, 21 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

503% more call options, than puts

Call options by funds: $4.1M | Put options by funds: $680K

36% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 11

5% more funds holding

Funds holding: 64 → 67 (+3)

10% less repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 21

58% less capital invested

Capital invested by funds: $268M → $113M (-$154M)

100% less funds holding in top 10

Funds holding in top 10: 5 → 0 (-5)

Holders
67
Holders Change
+3
Holders Change %
+4.69%
% of All Funds
1.67%
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
15
Increased
19
Reduced
21
Closed
11
Calls
$4.1M
Puts
$680K
Net Calls
+$3.42M
Net Calls Change
+$2.07M

Top Buyers

Rank Fund Capital Flow
1
GPP
Great Point Partners
Connecticut
+$6.56M
2
BlackRock
BlackRock
New York
+$4.97M
3
Jennison Associates
Jennison Associates
New York
+$3.27M
4
EU
Emory University
Georgia
+$1.96M
5
Axa
Axa
France
+$1.29M

Top Sellers

Rank Fund Capital Flow
1
MMH
Menora Mivtachim Holdings
Israel
-$12M
2
DM
Deerfield Management
New York
-$4M
3
DA
DSC Advisors
Illinois
-$3.59M
4
DCM
Driehaus Capital Management
Illinois
-$3.52M
5
GTC
Ghost Tree Capital
New York
-$2.31M
Name Holding Trade Value Shares
Change 		Change in
Stake
Creative Planning
51
Creative Planning
Kansas
$35K +$9.62K +1,000 +17%
PCM
52
Penserra Capital Management
California
$35K +$29.8K +3,093 +75%
TRCT
53
Tower Research Capital (TRC)
New York
$31K +$57.2K +5,945 +2,178%
Victory Capital Management
54
Victory Capital Management
Texas
$21K +$22.3K +2,313 +116%
Bank of America
55
Bank of America
North Carolina
$18K +$241 +25 +0.7%
Wells Fargo
56
Wells Fargo
California
$12K +$20.2K +2,100 +420%
Group One Trading
57
Group One Trading
Illinois
$12K +$22.5K +2,341 New
Citigroup
58
Citigroup
New York
$5K -$21.7K -2,258 -68%
UBS Group
59
UBS Group
Switzerland
$5K -$5.92K -615 -38%
LTFS
60
Ladenburg Thalmann Financial Services
Florida
$5K – – –
CG
61
Cutler Group
California
$5K +$8.62K +896 +560%
Bank of Montreal
62
Bank of Montreal
Ontario, Canada
$4K – – –
Barclays
63
Barclays
United Kingdom
$1K -$10.7K -1,107 -88%
IA
64
IFP Advisors
Florida
$1K – – –
JGC
65
J. Goldman & Co
New York
– -$1.75M -157,700 Closed
Federated Hermes
66
Federated Hermes
Pennsylvania
– -$555K -50,000 Closed
Neuberger Berman Group
67
Neuberger Berman Group
New York
– -$500K -45,000 Closed
TI
68
Trexquant Investment
Connecticut
– -$244K -22,000 Closed
Susquehanna International Group
69
Susquehanna International Group
Pennsylvania
– -$165K -17,114 Closed
CS
70
Credit Suisse
Switzerland
– -$173K -15,602 Closed
SG Americas Securities
71
SG Americas Securities
New York
– -$136K -12,230 Closed
PPA
72
Parametric Portfolio Associates
Washington
– -$113K -10,182 Closed
FANJ
73
Financial Architects (New Jersey)
New Jersey
– -$11K -1,000 Closed
AIM
74
Acrospire Investment Management
Illinois
– -$9K -811 Closed
JP Morgan Chase
75
JP Morgan Chase
New York
– -$7K -611 Closed
1 2
3
4

FOMX Hedge Fund Activity: Q1 2017 in Review

67 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) for Q1 2017, worth a combined $113M — down 58% from $268M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new FOMX positions and 11 closed out — a net gain of 4 holders — while 19 added to existing stakes and 21 trimmed.

The largest buyer was Great Point Partners, adding an estimated $6.56M. The largest seller was Menora Mivtachim Holdings, cutting an estimated $12M.

  • 67 institutional investors held Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) as of Q1 2017, up from 64 in Q4 2016.
  • Funds reported $113M of Foamix Pharmaceuticals Ltd. Ordinary Shares stock for Q1 2017, down 58% quarter-over-quarter.
  • 15 funds opened new Foamix Pharmaceuticals Ltd. Ordinary Shares positions in Q1 2017 and 11 closed out, a net change of +4 holders.
  • The largest Foamix Pharmaceuticals Ltd. Ordinary Shares buyer in Q1 2017 was Great Point Partners, an estimated $6.56M added.
  • The largest Foamix Pharmaceuticals Ltd. Ordinary Shares seller in Q1 2017 was Menora Mivtachim Holdings, an estimated $12M sold.

Based on aggregated 13F filings for Q1 2017.